title: Production and Administration of Therapeutic Mesenchymal Stem/Stromal Cell (MSC) Spheroids Primed in 3-D Cultures Under Xeno-free Conditions.
abstract: Mesenchymal stem/stromal cells (MSCs) hold great promise in bioengineering and regenerative medicine. MSCs can be isolated from multiple adult tissues via their strong adherence to tissue culture plastic and then further expanded in vitro, most commonly using fetal bovine serum (FBS). Since FBS can cause MSCs to become immunogenic, its presence in MSC cultures limits both clinical and experimental applications of the cells. Therefore, studies employing chemically defined xeno-free (XF) media for MSC cultures are extremely valuable. Many beneficial effects of MSCs have been attributed to their ability to regulate inflammation and immunity, mainly through secretion of immunomodulatory factors such as tumor necrosis factor-stimulated gene 6 (TSG6) and prostaglandin E2 (PGE2). However, MSCs require activation to produce these factors and since the effect of MSCs is often transient, great interest has emerged to discover ways of pre-activating the cells prior to their use, thus eliminating the lag time for activation in vivo. Here we present protocols to efficiently activate or prime MSCs in three-dimensional (3D) cultures under chemically defined XF conditions and to administer these pre-activated MSCs in vivo. Specifically, we first describe methods to generate spherical MSC micro-tissues or 'spheroids' in hanging drops using XF medium and demonstrate how the spheres and conditioned medium (CM) can be harvested for various applications. Second, we describe gene expression screens and in vitro functional assays to rapidly assess the level of MSC activation in spheroids, emphasizing the anti-inflammatory and anti-cancer potential of the cells. Third, we describe a novel method to inject intact MSC spheroids into the mouse peritoneal cavity for in vivo efficacy testing. Overall, the protocols herein overcome major challenges of obtaining pre-activated MSCs under chemically defined XF conditions and provide a flexible system to administer MSC spheroids for therapies.
authors.affiliation: Department of Biology, University of Mary Hardin-Baylor.
authors.forename: Joni H
authors.initials: JH
authors.lastname: Ylostalo
authors.affiliation: Department of Pediatrics, University of Texas Medical Branch.
authors.forename: Nikolay
authors.initials: N
authors.lastname: Bazhanov
authors.affiliation: Multi-Organ Support Technology Task Area, U.S. Army Institute of Surgical Research.
authors.forename: Arezoo
authors.initials: A
authors.lastname: Mohammadipoor
authors.affiliation: Internal Medicine, Texas A&M University Health Science Center; Bartosh@medicine.tamhsc.edu.
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Bartosh
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D002417:Cattle; D018929:Cell Culture Techniques; D049109:Cell Proliferation / Q000187:drug effects; D017077:Culture Media, Conditioned; D006801:Humans; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000378:metabolism; D051379:Mice; D010529:Peritoneal Cavity / Q000166:cytology*; D018874:Spheroids, Cellular / Q000166:cytology* / Q000378:metabolism
chemical_list: D015415:Biomarkers; D017077:Culture Media, Conditioned